Does Semaglutide or Tirzepatide Cause Hair Loss?

Hair loss has been reported during semaglutide and tirzepatide treatment. Observational studies support an association, but they do not establish that every case is caused by the medicine or that weight loss is the only explanation. Persistent or patchy loss deserves assessment rather than a promise that it will resolve.

What the studies show

Retrospective reports in the *Journal of the American Academy of Dermatology* examined hair loss during GLP-1 treatment.¹² A 2026 matched TriNetX study found higher odds of nonscarring hair loss with semaglutide and tirzepatide. People with hair-loss outcomes also had lower follow-up BMI, suggesting that weight-loss-related physiological stress may contribute.³

A separate 2026 BMJ study used electronic records to emulate treatment comparisons in adults with type 2 diabetes. GLP-1 initiation was associated with more alopecia than initiation of SGLT-2 or DPP-4 inhibitors; the authors described the absolute risk as low.⁴ These findings apply to defined populations and comparisons, not a personal prediction for every patient using a GLP-1 for weight management.

Why association does not settle the cause

These are observational analyses, not randomized tests of the mechanism of hair loss. Differences in underlying illness, treatment, nutrition and recording of diagnoses can affect the results. They do not rule out a direct drug contribution or show that weight loss explains every case.

Telogen effluvium is increased shedding after a disruption of the hair cycle. The British Association of Dermatologists lists marked weight loss and extreme dieting among possible triggers, alongside illness, childbirth and other stresses.⁵ That makes it a plausible explanation during weight management, not a diagnosis you can make from a prescription name.

Will the hair grow back?

Telogen effluvium often improves after the trigger resolves, but recovery takes time and other types of hair loss can coexist. A clinician may assess the scalp and history and consider tests for causes such as thyroid problems or iron deficiency.⁵ The GLP-1 cohort findings do not guarantee a regrowth timeline for you.

Bring a timeline of the medicine, dose changes, weight changes and when shedding began. Note whether loss is diffuse or patchy and whether you have scalp symptoms. Significant, worsening or patchy hair loss warrants discussion with a dermatologist or prescribing clinician.

What to do before changing treatment

Ask whether nutrition, another medicine or a separate condition needs assessment. Do not use a supplement, altered injection interval or faster dose escalation as a substitute for finding the cause. Our titration planner explains labeled schedules; it does not establish a schedule that prevents hair shedding.

Plan how to reach the clinical team between visits. The provider checklist covers follow-up questions, while the drug-interaction guide explains why a complete medication list matters. A program's coaching or messaging offer does not establish dermatology expertise or guarantee a referral.

This is editorial information, not medical advice. If you are experiencing significant or patchy hair loss, talk to a dermatologist or your prescribing clinician.